| Rodney Owen, | |
|
20900 Biscayne Blvd, Aventura, FL 33180-1407 | |
| (305) 682-2483 | |
| Not Available |
| Full Name | Rodney Owen |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 20900 Biscayne Blvd, Aventura, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720616733 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A184024 (California) | Primary |
| Entity Name | Ojai Emergency Physicians Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497152755 PECOS PAC ID: 3577889351 Enrollment ID: O20150313002134 |
News Archive
From the 63rd World Health Assembly (WHA) in Geneva, the Associated Press reports on what some "describe as a new strategy to get rid of" polio that focuses on developing solutions to "problems in each country, provides more WHO monitoring, like more teleconferences, and holds governments more accountable." The plans also provide "[n]ew [polio] outbreak response plans," according to the AP.
Cutting the umbilical cord doesn't necessarily sever the physical link between mother and child. Many cells pass back and forth between the mother and fetus during pregnancy and can be detected in the tissues and organs of both even decades later. This mixing of cells from two genetically distinct individuals is called microchimerism. The phenomenon is the focus of an increasing number of scientists who wonder what role these cells play in the body.
Norwegian researchers say that dopaminergic treatment should be considered for patients with early Parkinson's disease after finding that dopaminergic medication only has a minor impact on autonomic symptoms after 1 year.
Vivakor, Inc. announced today that its Board of Directors approved a dividend of shares of common stock of Regeneca International, Inc.. Vivakor previously received the shares from Regeneca in the fourth quarter of 2009 under a license agreement whereby Vivakor exclusively licensed to Regeneca, for the direct to consumer market, distribution rights to RegeneBlend, one of the new cutting-edge nutraceutical formulations developed by Vivakor.
A team of scientists at the University of Liverpool has secured the services of the National Biomanufacturing Centre (NBC) to develop and manufacture antibodies against a novel cancer antigen.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rodney Owen, 20900 Biscayne Blvd, Aventura, FL 33180-1407 Ph: (305) 682-2483 | Rodney Owen, 20900 Biscayne Blvd, Aventura, FL 33180-1407 Ph: (305) 682-2483 |
News Archive
From the 63rd World Health Assembly (WHA) in Geneva, the Associated Press reports on what some "describe as a new strategy to get rid of" polio that focuses on developing solutions to "problems in each country, provides more WHO monitoring, like more teleconferences, and holds governments more accountable." The plans also provide "[n]ew [polio] outbreak response plans," according to the AP.
Cutting the umbilical cord doesn't necessarily sever the physical link between mother and child. Many cells pass back and forth between the mother and fetus during pregnancy and can be detected in the tissues and organs of both even decades later. This mixing of cells from two genetically distinct individuals is called microchimerism. The phenomenon is the focus of an increasing number of scientists who wonder what role these cells play in the body.
Norwegian researchers say that dopaminergic treatment should be considered for patients with early Parkinson's disease after finding that dopaminergic medication only has a minor impact on autonomic symptoms after 1 year.
Vivakor, Inc. announced today that its Board of Directors approved a dividend of shares of common stock of Regeneca International, Inc.. Vivakor previously received the shares from Regeneca in the fourth quarter of 2009 under a license agreement whereby Vivakor exclusively licensed to Regeneca, for the direct to consumer market, distribution rights to RegeneBlend, one of the new cutting-edge nutraceutical formulations developed by Vivakor.
A team of scientists at the University of Liverpool has secured the services of the National Biomanufacturing Centre (NBC) to develop and manufacture antibodies against a novel cancer antigen.
› Verified 7 days ago
Christopher N Hanner, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2000 Island Blvd, #1605, Aventura, FL 33160 Phone: 305-725-2447 | |
Shuai Zhao, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 20900 Biscayne Blvd, Aventura, FL 33180 Phone: -- | |
Jaskirat Gill, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 20900 Biscayne Blvd, Aventura, FL 33180 Phone: 305-692-3392 | |
Jennifer Ashley Reyes, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 20900 Biscayne Blvd, Aventura, FL 33180 Phone: 512-636-5737 | |
Dr. Foluso Akinradewo, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 20900 Biscayne Blvd, Gme South Tower Room 821, Aventura, FL 33180 Phone: 305-692-3392 | |
Dr. Eva Ryder, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 20900 Biscayne Blvd, Aventura, FL 33180 Phone: 305-682-7000 | |
Trung Tran, MD, MPH Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 20900 Biscayne Blvd, Aventura, FL 33180 Phone: 305-692-3392 |